Abstract
We recently proposed a detailed model describing the dynamics of the network of cyclin-dependent kinases (Cdks) driving the mammalian cell cycle (Gérard and Goldbeter, ). The model contains four modules, each centered around one cyclin/Cdk complex. Cyclin D/Cdk4–6 and cyclin E/Cdk2 promote progression in G1 and elicit the G1/S transition, respectively; cyclin A/Cdk2 ensures progression in S and the transition S/G2, while the activity of cyclin B/Cdk1 brings about the G2/M transition. This model shows that in the presence of sufficient amounts of growth factor the Cdk network is capable of temporal self-organization in the form of sustained oscillations, which correspond to the ordered, sequential activation of the various cyclin/Cdk complexes that control the successive phases of the cell cycle. The results suggest that the switch from cellular quiescence to cell proliferation corresponds to the transition from a stable steady state to sustained oscillations in the Cdk network. The transition depends on a finely tuned balance between factors that promote or hinder progression in the cell cycle. We show that the transition from quiescence to proliferation can occur in multiple ways that alter this balance. By resorting to bifurcation diagrams, we analyze the mechanism of oscillations in the Cdk network. Finally, we show that the complexity of the detailed model can be greatly reduced, without losing its key dynamical properties, by considering a skeleton model for the Cdk network. Using such a skeleton model for the mammalian cell cycle we show that positive feedback (PF) loops enhance the amplitude and the robustness of Cdk oscillations with respect to molecular noise. We compare the relative merits of the detailed and skeleton versions of the model for the Cdk network driving the mammalian cell cycle.
Models for the CDK network driving the mammalian cell cycle
A network of cyclin-dependent kinases (Cdks) drives progression along the four successive phases G1, S (DNA replication), G2, and M (mitosis) of the mammalian cell cycle (Morgan, , ). When cells are not in a proliferative state, they remain in a quiescent phase, denoted G0. The Cdk network driving the mammalian cell cycle is controlled by multiple regulations involving a variety of intertwined negative and positive feedback (PF) loops. Due to the complexity of this regulatory network, it is necessary to resort to computational models to obtain a comprehensive picture of the dynamics of the cell cycle. Using a detailed model previously proposed for the Cdk network driving the mammalian cell cycle (Gérard and Goldbeter, ), or skeleton versions of this model (Gérard and Goldbeter, ; Gérard et al., ), we will illustrate how computational models can be used to investigate the dynamics of the cell cycle.
Modeling the mammalian cell cycle is an arduous task because of the very complexity of the Cdk network. For this reason, a number of models were proposed to account for parts of the mammalian cell cycle, such as the G1 phase and the G1/S transition (Qu et al., 2003; Swat et al., 2004; Alfieri et al., ; Pfeuty, 2012), the restriction point in G1 (Novak and Tyson, ), or the G2/M transition (Aguda, ). A model was also proposed to account for the regulation of mammalian cell cycle progression and its gating by the circadian clock in regenerating liver (Chauhan et al., ). Instead of focusing on a single transition between different phases of the cell cycle, we recently proposed a model for the dynamics of the global Cdk network driving the mammalian cell cycle (Gérard and Goldbeter, ). This model consists of four Cdk modules, each centered around one cyclin/Cdk complex. In its most detailed form this model contains no less than 39 variables. Involving multiple negative and PF loops exerted at the levels of cyclins or Cdks, the detailed model for the cell cycle accounts for the temporal self-organization of the Cdk network in the form of sustained oscillations of the various cyclin/Cdk complexes, corresponding to the progression along the successive phases of the cell cycle (Gérard and Goldbeter, ). We focus below on the properties of this detailed computational model and show how it can be simplified without losing its main dynamical properties.
In the detailed model for the Cdk network (see Figure 1), the synthesis of the various cyclins is regulated through the balance between the antagonistic effects exerted by the transcription factor E2F, which promotes, and the tumor suppressor pRB, which inhibits cell cycle progression. The Cdk network in turn regulates through phosphorylation the activity of E2F and pRB (Gérard and Goldbeter, ). Additional regulations in the detailed model for the Cdk network bear on the control exerted by the proteins Skp2, Cdh1, or Cdc20 on the degradation of cyclins E, A, and B at the G1/S or G2/M transitions, respectively. Finally, the activity of each cyclin/Cdk complex can itself be regulated through phosphorylation-dephosphorylation. The activity of cyclin D/Cdk4–6 is thus activated by phosphorylation by the cyclin-activated kinase (CAK) protein, while the Cdk2 and Cdk1 complexes are activated by the phosphatase Cdc25 and inhibited by the kinase Wee1. Multiple PF loops control the activation of the Cdks, because the phosphatases Cdc25 that activate the various Cdks are themselves activated through phosphorylation by the Cdks, while the latter inactivate their inhibitory kinase Wee1. The activity of the Cdks is further regulated through association with the protein inhibitor p21/p27 (Gérard and Goldbeter, ).
Figure 1
We previously showed that we may relinquish many of these biochemical details in building a skeleton, five-variable model for the mammalian cell cycle, without losing the key dynamical properties of the Cdk network (Gérard and Goldbeter,
Here, we shall first recapitulate the dynamical properties of the detailed model for the mammalian cell cycle (Gérard and Goldbeter,
Dysregulation of the cell cycle is closely associated with abnormal cell proliferation. The interest of a detailed model for the mammalian cell cycle is to allow us to address the nature of the transition from quiescence to cell proliferation. We will show how the detailed model for the cell cycle can be used to illustrate the anomalous passage of cells into a proliferative regime by an alteration of the balance between factors that promote, like the transcription factor E2F, or hinder, like the tumor suppressor pRB, cell cycle progression. We will explore multiple ways that elicit the passage from quiescence to proliferation. The same factors that cause this transition may also elicit the reverse transition from proliferation to cell cycle arrest, which is often a prerequisite for cell differentiation.
The presence of multiple PF loops in the regulation of the Cdk network is associated with abrupt switches in the activation of the various cyclin/Cdk complexes that drive the transitions between the successive phases of the cell cycle. A skeleton model for the mammalian cell cycle (Gérard et al.,
Results
A detailed model for the mammalian cell cycle
Oscillatory dynamics of the Cdk network
The analysis of the detailed model for the Cdk network driving the mammalian cell cycle indicates that when growth factors (GF) exceed a critical value, repetitive activation of the cyclin/Cdk complexes occurs in the form of self-sustained oscillations (Gérard and Goldbeter,
Figure 2

Sustained oscillations of the Cdk network in the detailed model for the mammalian cell cycle (Gérard and Goldbeter,
Balance between factors that promote or hinder progression in the cell cycle
The dynamic behavior of the Cdk network is controlled by a fine-tuned balance between factors that promote (oncogenes) or impede (tumor suppressors) progression in the cell cycle (Hanahan and Weinberg,
Figure 3

Antagonistic effects of the transcription factor E2F and the tumor suppressor pRB on cell cycle progression. The diagram shows the dynamical behavior of the Cdk network as a function of the rates of synthesis of E2F, vse2f, and pRB, vspRB. Regions in which the Cdk network evolves to a stable steady state, corresponding to cell cycle arrest, surround a domain of sustained oscillations, corresponding to cell proliferation. The domain of sustained oscillations is divided into two parts: in the lower part the oscillations depend on the presence of growth factor, GF (here, GF = 1 μM), while in the upper part of the domain they become independent of GF (GF = 0). Parameter values are as in Table S2 in Gérard and Goldbeter (
The domain of sustained oscillations is divided into two sub-domains: oscillations do or do not depend on the presence of growth factor. Thus, at a given level of E2F, oscillations can occur spontaneously in the Cdk network, in the absence of GF, at sufficiently low levels of pRB, but they require the presence of suprathreshold amounts of GF when the level of pRB increases. Similarly, at a given level of pRB, Cdk oscillations cease to require the presence of GF when the rate of E2F synthesis is sufficiently large. The model therefore allows us to distinguish between two types of oscillatory behavior in the Cdk network: cell proliferation that depends on GF might correspond to normal, healthy cell proliferation, while cell proliferation independent of GF might define a “cancer-like” cell (Hanahan and Weinberg,
Multiple ways to trigger the transition from quiescence to cell proliferation
The detailed model for the Cdk network (Gérard and Goldbeter,
Different ways to induce the transition from quiescence to proliferation are illustrated in Figure 4. In the detailed model for the Cdk network this transition is associated with the switch from a stable steady state to sustained oscillations around an unstable steady state. Thus, the model shows in (A) that the transition from a stable steady state, corresponding to quiescence, to a sustained oscillatory regime of the Cdk network, corresponding to cell proliferation, can be triggered by overexpression (starting in t = 120 h) of the protein AP1 involved in the synthesis of cyclin D that follows growth factor signaling. A similar transition can follow from overexpression of the transcription factor E2F involved in the synthesis of cyclin proteins (B), overexpression of Skp2, involved in the degradation of cyclin E (C), and from an increase in the level of the phosphatase Cdc25 involved in the activation of cyclin A/Cdk2 (D). Similarly, the model shows that a decrease in the tumor suppressor Cdh1 involved in the degradation of cyclin B (E), or a deletion of p53 (F), a factor that promotes the synthesis of the Cdk inhibitor p21, also elicit the transition from quiescence to proliferation.
Figure 4

Multiple ways to induce the passage from cellular quiescence to cell proliferation in the detailed model for the mammalian cell cycle. The switch to sustained oscillations of cyclin A/Cdk2 (in green) and cyclin B/Cdk1 (in red) is shown following the overexpression of AP1 (A), E2F (B), Skp2 (C), or Cdc25 (D), or the decrease of Cdh1 (E) or p53, via a decrease in p21 (F). In each case, from t = 120 h, the Cdk network passes from a stable steady state, corresponding to cellular quiescence, to an oscillatory regime corresponding to cell proliferation. From t = 120 h, the rate of synthesis of AP1, vsap1, passes from 1 to 2 μMh−1 in (A); the rate of synthesis of E2F, vse2f, passes from 0.15 to 0.5 μMh−1 in (B); the rate of synthesis of Skp2, vsskp2, passes from 0.15 to 0.5 μMh−1 in (C); the rate of synthesis of the phosphatase Cdc25 acting on cyclin A/Cdk2, vspai, increases from 0.105 to 0.25 μMh−1 in (D); the rate of synthesis of Cdh1, vscdh1a, decreases from 0.11 to 0.01 μMh−1 in (E); the level of p53, considered as a parameter that enhances the synthesis of p21–p27, passes from 0.8 to 0 in (F). For conditions (A) to (E), the rate of synthesis of pRB, vspRB is equal to 1.1 μMh−1. For condition (F), the rate of synthesis of p21–p27, vs1p27 [see Equation 24 in Gérard and Goldbeter (
The model therefore suggests that abusive transitions from quiescence to proliferation may have multiple causes converging to the same effect. The switch from steady state to sustained oscillations in the Cdk network might be responsible for the tumorigenic effect of an overexpression of oncogenes such as AP1 (Smith et al., 1999) or the phosphatase Cdc25 (Parsons, 1998; Ray and Kiyokawa, 2008), of a rise in the levels of the transcription factor E2F (Gala et al.,
Arresting the cell cycle in G1 as a prerequisite to cell differentiation
In mammals and, more generally, in most pluricellular organisms, cells divide and proliferate in a certain undifferentiated state. When appropriate conditions are met, cells initiate a program of cell differentiation (Quaroni et al., 2000; Buttitta et al.,
The detailed model for the cell cycle incorporates p21 and allows us to test the effect of its increase on the dynamics of the Cdk network. Overexpression of p21/p27 (Figure 5A) or of pRB (Figure 5B) can block the progression in the cell cycle, which stops in a state characterized by a high level of cyclin D/Cdk4–6 and a low level of the other cyclin/Cdk complexes, which corresponds to the G1 phase of the cell cycle. Such an arrest of the cell cycle might represent a first step in the process of cell differentiation. Further studies are needed to clarify the coupling between cell proliferation and cell differentiation (Hara et al.,
Figure 5

Arresting the mammalian cell cycle in the G1 phase. The curves show the time evolution of cyclin D/Cdk4–6 (in black), cyclin E/Cdk2 (in blue), cyclin A/Cdk2 (in green), and cyclin B/Cdk1 (in red) in the detailed model for the Cdk network. In t = 120 h, the transition from a sustained oscillatory regime of the Cdk network, corresponding to cell proliferation, to a stable steady state corresponding to cell cycle arrest follows the overexpression of p21–p27 when vs1p27 passes from 0.8 to 5 μMh−1(A), or the overexpression of pRB when vspRB passes from 0.8 to 1.2 μMh−1(B). The final, stable steady state is characterized by a high level of cyclin D/Cdk4–6 and low levels of the other cyclin/Cdk complexes, which could correspond to a cell cycle arrest in G1. Other parameter values are as in Table S2 in Gérard and Goldbeter (
The question arises as to why the system reaches a steady state characterized by higher levels of cyclin D/Cdk4–6 and lower levels of Cdk2 and Cdk1 when p21 or pRB are overexpressed. Cyclin D/Cdk4–6 in the time series represents the total active form of the kinase Cdk4–6, which is the sum of free cyclin D/Cdk4–6 and the complex between cyclin D/Cdk4–6 and p21/p27. The Cdk inhibitor p21/p27 does not inhibit the activity of cyclin D/Cdk4–6, but inhibits the activity of Cdk1 and Cdk2. Because we assume that cyclin D/Cdk4–6 is degraded only in the free state, it is protected by its binding to p21/p27. This explains why the total level of active cyclin D/Cdk4–6 increases when p21/p27 is overexpressed, while the level of Cdk2 and Cdk1 is low (see Figure 5A). On the other hand, pRB inhibits the synthesis of cyclin D/Cdk4–6, cyclin E/Cdk2 and cyclin A/Cdk2. Thus, it is counterintuitive to reach in Figure 5B a stable steady state with a high level of cyclin D/Cdk4–6 relative to Cdk2 and Cdk1 when pRB is overexpressed. While the synthesis of cyclin E/Cdk2 and cyclin A/Cdk2 is only regulated by E2F and pRB, the synthesis of cyclin D/Cdk4–6 is also regulated by GF. Two terms are present in the synthesis of cyclin D/Cdk4–6: the first depends on GF and the second depends on pRB and E2F. In our model, the rate of synthesis that depends on GF is ten times higher than the rate of synthesis that depends on pRB and E2F. Thus, overexpression of pRB will not decrease the level of cyclin D/Cdk4–6.
Endoreplication and tetraploidy
Endoreplication corresponds to uncoupling DNA replication from mitosis: the cell undergoes multiple rounds of DNA replication without entering into mitosis (Edgar and Orr-Weaver,
Figure 6

The Cdk network driving the mammalian cell cycle contains multiple oscillatory circuits (Gérard and Goldbeter,
The model shows that, depending on their degree of interconnection, these oscillatory circuits can produce simple periodic oscillations of the Cdk network that correspond to the mitotic cell cycle, to tetraploidy, or to endoreplication. One peak of Cdk2 is generally followed by one peak of Cdk1 per cycle, which case corresponds to the progression through the “classical” mitotic cell cycle (Figure 7A). Starting from this situation, a decrease in the rate of inhibition of the protein Cdh1 that is responsible for cyclin B degradation promotes the occurrence of endoreplication cycles: sustained oscillations of Cdk2 occur without significant oscillations of Cdk1 (Figure 7B). Reducing Cdh1 inhibition leads to a decrease in the level of cyclin B; such a decrease, with similar effects, can be obtained more directly by decreasing the rate of cyclin B synthesis. Thus, from the conditions yielding the mitotic cycle in Figure 7A, a first decrease in the rate of synthesis of cyclin B, vsb, can elicit tetraploidy (Figure 7C), where two peaks of Cdk2 are present for one peak of Cdk1. A further decrease in vsb generates again endoreplication cycles (Figure 7D). Tetraploidy will occur for the first cycle characterized by two peaks of Cdk2. For the subsequent cycles with two peaks of Cdk2, ploidy may increase if parameter conditions are maintained. Thus, for tetraploidy to occur, we must assume that a temporary change in some parameter value leads to inhibition of the Cdk1 module, and that this module may operate again when the altered parameters recover their original values.
Figure 7

Endoreplication or tetraploidy in the detailed model for the mammalian cell cycle. The curves show the time evolution of cyclin E/Cdk2 (in blue), cyclin A/Cdk2 (in green) and cyclin B/Cdk1 (in red) corresponding to the “classical” mitotic cell cycle in (A), to endoreplication cycles in (B) and (D); and to tetraploidy in (C). In (B), the rate of inhibition of Cdh1, V2cdh1, decreases from 8 to 2.5 h−1, which allows the occurrence of endoreplication cycles. The rate of synthesis of cyclin B decreases from 0.05 to 0.025 μM.h−1 in (C) and to 0.02 μM.h−1 in (D). In all cases, parameter values are as in Table S2 in Gérard and Goldbeter (
These results suggest that the transition from a “normal” cell cycle to endoreplication or tetraploidy may be promoted in multiple ways, for example through overactivation of Cdh1 (Sorensen et al., 2000) or a decrease in cyclin B synthesis. In all cases, the model shows that the occurrence of endoreplication cycles may be readily achieved by inhibiting the activity of the Cdk1 module that controls the G2/M transition; this prediction is in agreement with experimental observations (Larkins et al.,
The interactions between the different oscillatory circuits present in the Cdk network can also lead to complex dynamical behaviors such as complex periodic oscillations, quasi-periodic oscillations, and chaos (Gérard and Goldbeter,
Oscillatory dynamics in presence of DNA replication checkpoint
Checkpoints ensure that cells progress in the next phase of the cell cycle only if the preceding phase is completed correctly (Hartwell and Weinert,
At the G1/S transition, cyclin E/Cdk2 activates by phosphorylation the anchor factor Cdc45, which permits the binding of DNA polymerase α to DNA and the initiation of DNA replication (see Figure 8). The kinase ATR is activated upon binding the RNA primer synthesized by DNA polymerase α. ATR phosphorylates, and thereby activates, the kinase Chk1. Once activated, Chk1 inhibits the Cdc25 phosphatases; this inhibition blocks cell cycle progression by preventing the activation of Cdk2 and Cdk1 as long as DNA replication proceeds. Finally the decrease in Cdk2 activity, inherent to the oscillatory dynamics of the Cdk network, inhibits DNA polymerase at the end of the S phase (Dart et al.,
Figure 8

Scheme of the DNA replication checkpoint regulated by kinases ATR and Chk1. At the G1/S transition, cyclin E/Cdk2 activates, by phosphorylation, the anchor factor Cdc45 that allows DNA polymerase α to bind to DNA. Upon initiation of DNA replication, DNA polymerase α synthesizes an RNA primer, which binds and activates the kinase ATR. The active form of ATR activates, by phosphorylation, the kinase Chk1. Once activated, Chk1 inhibits, by phosphorylation, the phosphatases Cdc25 responsible for the activation of cyclin E/Cdk2, cyclin A/Cdk2, and cyclin B/Cdk1. The inhibition of cyclin E/Cdk2 and cyclin A/Cdk2 during DNA replication creates a checkpoint, which limits the activation of Cdc45 and thereby prevents excessive initiation of DNA synthesis at multiple points of origin of DNA replication. At the end of DNA replication, cyclin E/Cdk2 is further inhibited due to the degradation of cyclin E, brought about by the rise in Skp2, which follows from the inactivation of Cdh1 by cyclin A/Cdk2—see Figure 1 and (Gérard and Goldbeter,
The model shows that the DNA replication checkpoint does not alter qualitatively the oscillatory nature of the dynamics of the Cdk network. However, it slows down the progression in the cell cycle and allows for a better separation between DNA replication and mitosis (Figure 9). Indeed, when the checkpoint is inactivated, we observe an overlap between the peak of activity of DNA polymerase α, which is a marker of the S phase, and the peak of cyclin B/Cdk1, which corresponds to the M phase (Figure 9A). In the presence of mild (Figure 9B) or strong activation (Figure 9C) of the checkpoint, the progression in the cell cycle slows down: the period of the cell cycle passes from 19 h in (A) to 21.6 h in (B) and 31 h in (C). Moreover, the checkpoint allows for better separation between DNA replication and mitosis (compare panel C with panels B and, even more strikingly, A). This ensures that the cell completes DNA replication before entering mitosis.
Figure 9

Effect of the DNA replication checkpoint on Cdk oscillations in the detailed model for the Cdk network driving the mammalian cell cycle. The time evolution of cyclin E/Cdk2 (in blue), DNA polymerase α (in black) and cyclin B/Cdk1 (in red) is shown (A) in the absence of activation of the kinase ATR driving the DNA replication checkpoint, with kaatr = 0, or in the presence of low (B) or strong activation (C) of the kinase ATR, with kaatr = 0.01 μM−1.h−1 in (B) and 0.024 μM−1.h−1 in (C). The presence of the DNA replication checkpoint slows down the progression in the cell cycle: the period of the cell cycle clock passes from 19 h in (A), to 21.6 h in (B) and 31 h in (C). Moreover, the DNA replication checkpoint improves the separation between the phase of DNA replication, represented by the peak of DNA polymerase α and the phase of mitosis, represented by the peak of cyclin B/Cdk1. Other parameter values are as in Table S2 in Gérard and Goldbeter (
Mechanism of oscillations in the Cdk network
The dynamics of the Cdk network is governed by multiple positive and negative feedback loops that involve the various cyclin/Cdk complexes. At the end of the network, the last Cdk module that controls the G2/M transition is regulated by a negative feedback loop between cyclin B/Cdk1 and APC/Cdc20 (see Figure 1). The earlier modules that control the progression from G1 to S, G2, and M harbor a cascade of bistable switches in the activation of the various cyclin/Cdk complexes. Indeed, as previously stressed in experimental as well as theoretical studies, PF loops control the dynamics of the G1/S as well as the G2/M transitions of the cell cycle (Hoffmann et al.,
The dynamics of the Cdk network that governs progression from G1 to S, G2, and M is illustrated in Figure 10 in the detailed model for the Cdk network driving the mammalian cell cycle. First the time evolution of pRB and E2F is illustrated in (A). These antagonistic factors oscillate in antiphase. A high level of pRB and a low level of E2F characterize the G1 phase of the cell cycle. By eliciting the synthesis of the various cyclins, the rise in E2F promotes progression in the G1, S, and G2 phases of the cell cycle.
Figure 10

Mechanism of oscillations in the Cdk network. (A) The curves show the time evolution of the active, unphosphorylated, forms of E2F (in green) and pRB (in red) which oscillate in antiphase. (B) Bifurcation diagram showing the steady-state level of cyclin A/Cdk2 as a function of E2F, considered as a parameter. Two stable steady states coexist in the domain of bistability. The sharp increase in cyclin A/Cdk2 above a critical level of E2F favors progression from the cell cycle phase G1 to S and G2. (C) Bifurcation diagram showing the steady-state level of cyclin B/Cdk1 as a function of cyclin A/Cdk2, considered as a parameter. A domain of sustained oscillations exists above a critical level of cyclin A/Cdk2; the upper and lower blue curves denote the maximum and minimum of cyclin B/Cdk1 oscillations as a function of cyclin A/Cdk2. The rise in the level of cyclin A/Cdk2 pushes transiently the system into the domain of sustained oscillations, which permits the activation of cyclin B/Cdk1 at the G2/M transition. The rise in cyclin B/Cdk1 leads to the activation of the protein Cdc20, which promotes the degradation of cyclins A and B; this creates a negative feedback loop in the activation of cyclin A/Cdk2 and cyclin B/Cdk1. The subsequent decrease in the levels of cyclin A/Cdk2 and cyclin B/Cdk1 resets the system and a new cell cycle starts again in G1 if GF is present in sufficient amount. Black curves in (C) represent stable steady states, red dashed curves represent unstable states. (D) Superimposed on the bifurcation diagram of cyclin B/Cdk1 vs. cyclin A/Cdk2 in (C) is the projection of the limit cycle oscillations (green trajectory, with arrows indicating the direction of movement along the limit cycle) in the plane defined by cyclin A/Cdk2 and cyclin B/Cdk1 (Gérard and Goldbeter,
A bifurcation diagram illustrating the dynamical behavior of cyclin A/Cdk2 as a function of the transcription factor E2F (considered as a parameter) is shown in (B). This second module of the network controls the progression from G1 to S and G2. In early G1, the level of E2F is low, which allows the maintenance of a low level of cyclin A/Cdk2. The rise in E2F during G1 elicits an abrupt increase in the level of cyclin A/Cdk2, as soon as E2F reaches the limit point of the bistable switch. Such an abrupt activation elicits progression in S and G2 and contributes to render the G1/S transition irreversible (B). The bistable behavior in the activation of Cdk2 results from the presence of the PF regulation of cyclin E/Cdk2 (not shown) and cyclin A/Cdk2, via the activation of their phosphatase Cdc25. Later, during G2, the level of E2F will decrease because cyclin A/Cdk2 promotes its degradation by phosphorylation (Gérard and Goldbeter,
The abrupt rise in the level of cyclin A/Cdk2 permits the activation of cyclin B/Cdk1 at the G2/M transition: the increase in cyclin A/Cdk2 pushes the Cdk network into a domain of sustained oscillations of Cdk1 (see the bifurcation diagram established in Figure 10C for cyclin B/Cdk1 as a function of cyclin A/Cdk2, considered as a parameter). The occurrence of oscillations results from the negative feedback loop between cyclin B/Cdk1 and Cdc20 (see Figure 1). However, the entry of Cdk1 in the domain of sustained oscillations in (C) is only transient. This is made clear in (D) where the projection of the limit cycle trajectory followed by the full Cdk network in the cyclin A/Cdk2 vs. cyclin B/Cdk1 plane is superimposed on the bifurcation diagram shown in (C). There is only one peak of Cdk1 when the last module enters the oscillatory domain: indeed, soon after this peak, cyclin A/Cdk2 begins to decrease because cyclin B/Cdk1 activates, through phosphorylation, the protein Cdc20 that triggers degradation of both cyclins A and B. As cyclin A/Cdk2 decreases, soon followed by a decrease in Cdk1, the Cdk1 module leaves its domain of sustained oscillations (C and D). This completes the M phase of the cell cycle and leads to a return to G1, characterized by low levels of activity of the various cyclin/Cdk complexes.
The detailed model for the Cdk network thus shows that the presence of multiple PF loops elicit a cascade of abrupt activation of the various cyclin/Cdk complexes, which controls the progression from G1 to S, G2, and M. At the G2/M transition, the cell enters transiently into an oscillatory regime; the pulsatile increase in Cdk1 at the same time triggers the M phase and resets the cycle. The cell division cycle can thus be viewed as a cascade of dominoes, controlled by PF loops, which drives the ordered transition along the successive phases of the cell cycle. The negative feedback loops between Cdk1 and Cdc20 at the end of the network turns the bistable behavior of the different Cdk modules into a global limit cycle oscillator. The reset brought about by the rise in Cdk1 allows the cell to start a new cycle spontaneously if appropriate conditions are met. The mammalian cell cycle thus behaves as a self-organized, oscillating cascade of dominoes. Such a conclusion reconciles two views of the cell cycle, as dominoes and clock (Murray and Kirschner,
Coupling the cell cycle to the circadian clock
Several molecular components of the cell cycle network are regulated in a circadian manner (Fu et al.,
In the presence of coupling to the circadian clock (see Figure 11, for t > 120 h), the model shows that autonomous periods of the cell cycle smaller, e.g., 20 h in (A), or larger than 24 h, e.g., 28 h in (B), can be entrained to oscillate at a circadian period (Gérard and Goldbeter,
Figure 11

Entrainment of the mammalian cell cycle by the circadian clock (Gérard and Goldbeter,
Previous studies have established the existence of a link between dysregulation of circadian rhythms and cancer (Filipski et al.,
A skeleton model for the mammalian cell cycle
Building a skeleton model for the Cdk network
The question arises as to whether the complexity of the detailed model for the Cdk network can be reduced without losing the insights provided by this model. We have shown that most of the results on the oscillatory dynamics can indeed be retained when the number of variables and parameters are significantly reduced in a skeleton model for the Cdk network. A necessary price must be paid for this reduction in complexity. We have to abandon a large number of biochemical details while trying to retain the logic of the regulatory wiring of the Cdk network. The advantage of reducing the number of variables is that the system becomes more amenable to a thorough numerical analysis of its dynamical properties, both in its deterministic and stochastic versions.
A first version of the skeleton network (Gérard and Goldbeter,
The extended skeleton model for the Cdk network is schematized in Figure 12 (see also Gérard et al.,
Figure 12

Scheme of the extended skeleton model for the mammalian cell cycle (Gérard et al.,
Figure 13

Oscillatory dynamics of the skeleton model for the Cdk network driving the mammalian cell cycle: role of zero-order ultrasensitivity (ZOU) and positive feedback. The curves show the time evolution of cyclin E/Cdk2 (in blue) and cyclin B/Cdk1 (in red) in the presence of mild ultrasensitivity (K = 0.1 μM in A and C) or strong ultrasensitivity (K = 0.005 μM in B and D), and in the absence of any PF loop (b1 = 0, b2 = 0, Kib = 1000 μM in A,B) or presence (b1 = 1, b2 = 1, Kib = 0.5 μM in C,D) of three PF loops. The presence of PF loops as well as the presence of strong ultrasensitivity enhance the amplitude of Cdk oscillations (compare panels A and B with C and D). With the value of parameters used in the simulations, the Cdk network tends to a stable steady state in the presence of mild ultrasensitivity and in the absence of any PF loop (A). This result fits with experimental observations showing that bypassing PF loops produces damped oscillations of the cyclin/Cdk complexes (Pomerening et al., 2005). Parameter values are as in Table 2 in Gérard et al. (
Oscillations in the skeleton model for the Cdk network: role of ultrasensitivity and positive feedback loops
The skeleton, five-variable, model or the Cdk network is also capable of temporal self-organization in the form of sustained oscillations. As in the detailed model for the cell cycle, sustained oscillations of the various cyclin/Cdk complexes correspond to the evolution toward a limit cycle, which can be reached regardless of initial conditions (Gérard and Goldbeter,
A number of experimental and theoretical studies, mostly devoted to the early cell cycles in amphibian embryos (Goldbeter,
The time evolution of cyclin E/Cdk2 and cyclin B/Cdk1 in the extended version of the skeleton model is shown in the presence of mild (Figures 13A,C) or strong ultrasensitivity (Figures 13B,D), and in the absence (Figures 13A,B) or presence (Figures 13C,D) of 3 PF loops in the G1/S and G2/M transitions of the cell cycle. The presence of PF loops as well as the degree of ultrasensitivity in phosphorylation–dephosphorylation of Cdk1 and Cdk2 contribute to the robustness of oscillations in the Cdk network by augmenting their amplitude (see Gérard et al.,
The presence of PF loops also increases the robustness of Cdk oscillations toward molecular noise (Gérard et al.,
Figure 14

Positive feedback loops increase the robustness of Cdk oscillations with respect to molecular noise. The long-term time evolution of cyclin B/Cdk1 is shown in the extended version of the skeleton model for the mammalian cell cycle (Gérard et al.,
Figure 15

Positive feedback loops increase the robustness of limit cycle oscillations in the Cdk network. Projection of the stochastic limit cycle (black curve) and the corresponding deterministic limit cycle (red curve) in the cyclin A/Cdk2 vs. cyclin B/Cdk1 plane. Numerical simulations were performed in the extended version of the skeleton model for the mammalian cell cycle (Gérard et al.,
Discussion
The use of computational models is justified in Systems Biology by the complexity of cellular networks in which large numbers of variables are coupled through multiple regulatory interactions. When addressing by means of computational modeling the dynamics of the Cdk network that drives the mammalian cell cycle, we first have to deal with the very complexity of this key cellular regulatory system: what level of biochemical detail is most appropriate for grasping the dynamics of this key cellular network? Here we showed that it is possible to address this key issue in several, complementary ways. We first built a rather detailed model for the Cdk network that allows a thorough analysis of its dynamic behavior in physiological and pathological conditions. In a second stage we indicated how to reduce the complexity of this detailed model by considering a skeleton version in which many biochemical details are relinquished. The skeleton model, based on the same regulatory backbone, retains most dynamical properties of the detailed one.
The two versions of the model for the Cdk network schematized in Figures 1 and 12, respectively, differ markedly by the number of variables: 39 in the detailed model (Gérard and Goldbeter,
The 39-variable model already represents a reduced version of a full model for the Cdk network, because enzymatic reactions are assumed to obey Michaelis–Menten kinetics. This assumption is not necessarily valid, because substrates of kinases and phosphatases, such as Cdks, are themselves kinases and are therefore not necessarily in excess with respect to the enzymes that catalyze their covalent modification. In such a case, one can either use an extended form of the Michaelis–Menten equation (Segel, 1988; Ciliberto et al.,
Because it incorporates the main actors of the cell cycle control machinery, the 39-variable model is particularly useful to study the behavior of the Cdk network in the presence of overexpression or deletion of a variety of factors that impinge on the dynamics of the cell cycle. The model indicates that a balance between proteins that promote (oncogenes) or hinder (tumor suppressors) governs progression in the cell cycle. The role of this balance is well illustrated by the antagonistic effects of pRB, which inhibits, and E2F, which promotes, progression in the cell cycle (Figure 3). The model shows that, depending on the relative levels of E2F and pRB, cell proliferation can become independent of the presence of growth factor. Such independence is often considered as a hallmark of cancer cells, many of which do not require the presence of growth factor to proliferate, when they do not secrete themselves their own growth factor (Hanahan and Weinberg,
The computational approach provides a true systemic view of the dynamics of the Cdk network that drives the mammalian cell cycle. Thus, it shows that there are multiple ways to trigger the transition from cellular quiescence to cell proliferation. As illustrated in Figure 4, this transition could be achieved by overexpressing oncogenes or transcription factors, or by repressing tumor suppressors or Cdk inhibitors. Any permanent change that tilts the balance from quiescence to proliferation will trigger the transition from steady state to sustained Cdk oscillations. The resulting abusive progression in the cell cycle might correspond to the dynamical behavior of cancer cells (Hanahan and Weinberg,
The behavior of the detailed model for the Cdk network can be compared with a large number of experimental observations on the mammalian cell cycle. Such a comparison bears on the existence of a restriction point in G1 beyond which the cell does not need the presence of growth factor to complete a cycle (Gérard and Goldbeter,
The computational approach to the cell cycle further allows us to study the transition between cellular proliferation and cell differentiation, which begins by arresting the cell cycle in G1. Such an arrest in the G1 phase can be achieved by overexpressing p21/p27 or pRB, as shown in Figure 5. This cell cycle arrest might correspond to a prerequisite to cell differentiation (Evers,
The dynamics of the cell cycle is controlled by the presence of multiple checkpoints, which ensure correct progression in the cell cycle (Hartwell and Weinert,
In analyzing the mechanism of Cdk oscillations in the detailed model for the mammalian cell cycle, we used bifurcation diagrams to show that the dynamical behavior of the Cdk network rests on a cascade of bistable switches in the activation of the various cyclin/Cdk complexes that govern progression in G1, S, G2, and M (see Figure 10). Such a bifurcation analysis has previously been used for studying the dynamics of the yeast and mammalian cell cycles, considering cell mass as bifurcation parameter (Novak and Tyson,
The detailed model for the Cdk network was also used to study entrainment of the cell cycle by the circadian clock through circadian control of the kinase Wee1 (see Figure 11 and also Gérard and Goldbeter,
In building a skeleton version of the Cdk network we aimed at reducing the number of variables without losing the backbone of its regulatory structure. Thus, we abandoned many variables, such as pRB or Cdh1, and biochemical details, but kept the essential ingredient of the regulatory wiring: each Cdk module promotes the activation of subsequent Cdk modules and inhibits the previous modules in the network (Gérard and Goldbeter,
Numerous studies have emphasized the role of PF loops and bistability in the dynamics of the cell cycle. This aspect has been addressed both in experiments and in models for the early cell cycles in amphibian embryos (Goldbeter,
Due to its relative simplicity and smaller numbers of variables and parameters, the skeleton model for the Cdk network is particularly helpful for studying the effect of PF loops on the dynamics of the cell cycle (Gérard et al.,
Detailed models for the Cdk network can help to highlight the differences that might arise from a dynamical point of view between the cell cycle in healthy and cancer cells as a result of overexpression of oncogenes and/or deletion of tumor suppressors (Gérard and Goldbeter,
Models of increasing complexity have been discussed here for the Cdk network driving the mammalian cell cycle. They range from a detailed, 39-variable model to a skeleton model containing only five variables. Much as an even more complex version of the detailed model, which counts no less than 80 variables (Gérard and Goldbeter,
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Statements
Acknowledgments
This work was supported by grant n° 3.4607.99 from the Fonds de la Recherche Scientifique Médicale (F.R.S.M., Belgium), the Belgian Federal Science Policy Office (IAP P6/25 “BioMaGNet”: “Bioinformatics and Modeling- From Genomes to Networks”), and the F.R.S.-FNRS (Belgium) in conjunction with the ErasysBio+ project C5Sys, “Circadian and Cell Cycle Clock Systems in Cancer.” Claude Gérard currently holds a postdoctoral fellowship from the Foundation Philippe Wiener—Maurice Anspach in the Department of Biochemistry at the University of Oxford.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Research Topic:
Topic Editor:
Matteo Barberis, Humboldt University Berlin, Germany; Max Planck Institute for Molecular Genetics, Berlin, Germany
References
1
AgudaB. D. (1999). A quantitative analysis of the kinetics of the G2 DNA damage checkpoint system. Proc. Natl. Acad. Sci. U.S.A. 96, 11352–11357. 10.1073/pnas.96.20.11352
2
AlfieriR.BarberisM.ChiaradonnaF.GaglioD.MilanesiL.VanoniM.et al. (2009). Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation. BMC Bioinformatics10:S16. 10.1186/1471-2105-10-S12-S16
3
BarikD.BaumannW. T.PaulM. R.NovakB.TysonJ. J. (2010). A model of yeast cell-cycle regulation based on multisite phosphorylation. Mol. Syst. Biol. 6, 405. 10.1038/msb.2010.55
4
BjarnasonG. A.JordanR.SothernR. B. (1999). Circadian variation in the expression of the cell-cycle proteins in human oral epithelium. Am. J. Pathol. 154, 613–622. 10.1016/S0002-9440(10)65306-0
5
ButtittaL. A.KatzaroffA. J.PerezC. L.de la CruzA.EdgarB. A. (2007). A double-assurance mechanism controls cell cycle exit upon terminal differentiation in drosophila. Dev. Cell12, 631–643. 10.1016/j.devcel.2007.02.020
6
ChauB. N.WangJ. Y. J. (2003). Coordinated regulation of life and death by RB. Nat. Rev. Cancer3, 130–138. 10.1038/nrc993
7
ChauhanA.LorenzenS.HerzelH.BernardS. (2011). Regulation of mammalian cell cycle progression in the regenerating liver. J. Theor. Biol. 283, 103–112. 10.1016/j.jtbi.2011.05.026
8
ChenK. C.CalzoneL.Csikasz-NagyA.CrossF. R.NovakB.TysonJ. J. (2004). Integrative analysis of cell cycle control in budding yeast. Mol. Biol. Cell15, 3841–3862. 10.1091/mbc.E03-11-0794
9
CilibertoA.CapuaniF.TysonJ. J. (2007). Modeling networks of coupled enzymatic reactions using the total quasi-steady state approximation. PLoS Comput. Biol. 3:e45. 10.1371/journal.pcbi.0030045
10
DartD. A.AdamsK. E.AkermanI.LakinN. D. (2004). Recruitment of the cell cycle checkpoint kinase ATR to chromatin during S-phase. J. Biol. Chem. 279, 16433–16440. 10.1074/jbc.M314212200
11
DirickL.NasmythK. (1991). Positive feedback in the activation of G1 cyclins in yeast. Nature351, 754–757. 10.1038/351754a0
12
DoedelE. J. (1981). AUTO: a program for the automatic bifurcation analysis of autonomous systems. Congr. Numer. 30, 265–284.
13
Domingo-SananesM. R.KapuyO.HuntT.NovakB. (2011). Switches and latches: a biochemical tug-of-war between the kinases and phosphatases that control mitosis. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366, 3584–3594. 10.1098/rstb.2011.0087
14
EdgarB. A.Orr-WeaverT. L. (2001). Endoreplication cell cycles: more for less. Cell105, 297. 10.1016/S0092-8674(01)00334-8
15
EversB. M. (1999). Intestinal cell differentiation: cellular mechanisms and the search for the perfect model focus on “involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation.”Am. J. Physiol. 276, C1243–C1244.
16
FerrellJ. E.Jr.MachlederE. M. (1998). The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science280, 895–898. 10.1126/science.280.5365.895
17
FerrellJ. E.Jr.PomereningJ. R.KimS. Y.TrunnellN. B.XiongW.HuangC. Y.et al. (2009). Simple, realistic models of complex biological processes: positive feedback and bistability in a cell fate switch and a cell cycle oscillator. FEBS Lett. 583, 3999–4005. 10.1016/j.febslet.2009.10.068
18
FilipskiE.KingV. M.LiX. M.GrandaT. G.MormontM. C.LiuX.et al. (2002). Host circadian clock as a control point in tumor progression. J. Natl. Cancer Inst. 94, 690–697. 10.1093/jnci/94.9.690
19
FuL.LeeC. C. (2003). The circadian clock: pacemaker and tumour suppressor. Nature3, 350–361. 10.1038/nrc1072
20
FuL.PelicanoH.LiuJ.HuangP.Chi LeeC. (2002). The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell111, 41–50. 10.1016/S0092-8674(02)00961-3
21
GalaS.MarreirosA.StewartG. J.WilliamsonP. (2001). Overexpression of E2F-1 leads to cytokine-independent proliferation and survival in the hematopoietic cell line BaF-B03. Blood97, 227–234. 10.1182/blood.V97.1.227
22
Garcia-HigueraI.ManchadoE.DubusP.CanameroM.MéndezJ.MorenoS.et al. (2008). Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat. Cell Biol. 10, 802–811. 10.1038/ncb1742
23
GaugerM. A.SancarA. (2005). Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res. 65, 6828–6834. 10.1158/0008-5472.CAN-05-1119
24
GérardC.GoldbeterA. (2009). Temporal self-organization of the cyclin/Cdk network driving the mammalian cell cycle. Proc. Natl. Acad. Sci. U.S.A. 106, 21643–21648. 10.1073/pnas.0903827106
25
GérardC.GoldbeterA. (2010). From simple to complex patterns of oscillatory behavior in a model for the mammalian cell cycle containing multiple oscillatory circuits. Chaos20, 045109. 10.1063/1.3527998
26
GérardC.GoldbeterA. (2011). A skeleton model for the network of cyclin-dependent kinases driving the mammalian cell cycle. Interface Focus1, 24–35. 10.1111/j.1742-4658.2012.08585.x
27
GérardC.GoldbeterA. (2012a). Entrainment of the mammalian cell cycle by the circadian clock: modeling two coupled cellular rhythms. PLoS Comput. Biol. 8:e1002516. 10.1371/journal.pcbi.1002516
28
GérardC.GoldbeterA. (2012b). The cell cycle is a limit cycle. Math. Mod. Nat. Phenom. 7. (in press).
29
GérardC.GonzeD.GoldbeterA. (2012). Effect of positive feedback loops on the robustness of oscillations in the network of cyclin-dependent kinases driving the mammalian cell cycle. FEBS J. 279, 3411–3431. 10.1111/j.1742-4658.2012.08585.x
30
GoldbeterA. (1991). A minimal cascade model for the mitotic oscillator involving cyclin and cdc2 kinase. Proc. Natl. Acad. Sci. U.S.A. 88, 9107–9111.
31
GoldbeterA. (1993). Modeling the mitotic oscillator driving the cell division cycle. Comments Theor. Biol. 3, 75–107.
32
GoldbeterA. (1996). Biochemical Oscillations and Cellular Rhythms. The Molecular Bases of Periodic and Chaotic Behaviour. Cambridge, UK: Cambridge University Press.
33
GoldbeterA.GérardC.GonzeD.LeloupJ.-C.DupontG. (2012). Systems biology of cellular rhythms. FEBS Lett. 586, 2955–2965. 10.1016/j.febslet.2012.07.041
34
GoldbeterA.KoshlandD. E.Jr. (1981). An amplified sensitivity arising from covalent modification in biological systems. Proc. Natl. Acad. Sci. U.S.A. 78, 6840–6844.
35
GonzeD.HafnerM. (2010). Positive feedbacks contribute to the robustness of the cell cycle with respect to molecular noise, in Adv. in Theory of Control, Signals, LNCIS 407, eds LévineJ.MüllhauptP. (Germany: Springer-Verlag), 283–295.
36
Gréchez-CassiauA.RayetB.GuillaumondF.TeboulM.DelaunayF. (2008). The circadian clock component Bmal1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J. Biol. Chem. 283, 4535–4542. 10.1074/jbc.M705576200
37
GunawardenaJ. (2005). Multisite protein phosphorylation makes a good threshold but can be a poor switch. Proc. Natl. Acad. Sci. U.S.A. 102, 14617–14622. 10.1073/pnas.0507322102
38
HanahanD.WeinbergR. A. (2000). The hallmarks of cancer. Cell100, 57–70. 10.1016/S0092-8674(00)81683-9
39
HaraT.MiyazakiM.HakunoF.TakahashiS.ChidaK. (2011). PKCη promotes a proliferation to differentiation switch in keratinocytes via upregulation of p27Kip1 mRNA through suppression of JNK/c-Jun signaling under stress conditions. Cell Death Dis. 2, e157. 10.1038/cddis.2011.40
40
HarbourJ. W.DeanD. C. (2000). The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393–2409. 10.1101/gad.813200
41
HartwellL. H.WeinertT. A. (1989). Checkpoints: controls that ensure the order of cell cycle events. Science246, 629–634. 10.1126/science.2683079
42
HoffmannI.DraettaG.KarsentiE. (1994). Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 13, 4302–4310.
43
IlyinG. P.GlaiseD.GilotD.BaffetG.Guguen-GuillouzoC. (2003). Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G115–G127. 10.1152/ajpgi.00309.2002
44
InnominatoP. F.MormontM. C.RichT. A.WaterhouseJ.LéviF. A.BjarnasonG. A. (2009). Circadian disruption, fatigue, and anorexia clustering in advanced cancer patients: implications for innovative therapeutic approaches. Integr. Cancer Ther. 8, 361–370.
45
KimS. Y.FerrellJ. E.Jr. (2007). Substrate competition as a source of ultrasensitivity in the inactivation of Wee1. Cell128, 1133–1145. 10.1016/j.cell.2007.01.039
46
LarkinsB. A.DilkesB. P.DanteR. A.CoelhoC. M.WooY.-M.LiuY. (2001). Investigating the hows and whys of DNA endoreduplication. J. Exp. Botany52, 183–192. 10.1093/jexbot/52.355.183
47
LeloupJ.-C.GoldbeterA. (2003). Toward a detailed computational model for the mammalian circadian clock. Proc. Natl. Acad. Sci. U.S.A. 100, 7051–7056. 10.1073/pnas.1132112100
48
LevineA. J. (1997). p53, the cellular gatekeeper for growth and division. Cell88, 323–331. 10.1016/S0092-8674(00)81871-1
49
MatsuoT.YamaguchiS.MitsuiS.EmiA.ShimodaF.OkamuraH. (2003). Control mechanism of the circadian clock for timing of cell division in vivo. Science302, 255–259. 10.1126/science.1086271
50
MorganD. O. (1995). Principles of Cdk regulation. Nature374, 131–134. 10.1038/374131a0
51
MorganD. O. (2006). The Cell Cycle: Principles of Control. UK: Oxford University Press.
52
MurrayA. W.KirschnerM. W. (1989). Dominoes and clocks: the union of two views of the cell cycle. Science246, 614–621. 10.1126/science.2683077
53
NigroJ. M.BakerS. J.PreisingerA. C.JessupJ. M.HostetterR.ClearyK.et al. (1989). Mutations in the p53 gene occur in diverse human tumour types. Nature342, 705–708. 10.1038/342705a0
54
NovakB.TysonJ. J. (1993). Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos. J. Cell Sci. 106, 1153–1168.
55
NovakB.TysonJ. J. (2004). A model for restriction point control of the mammalian cell cycle. J. Theor. Biol. 230, 563–579. 10.1016/j.jtbi.2004.04.039
56
NovakB.TysonJ. J.GyorffyB.Csikasz-NagyA. (2007). Irreversible cell-cycle transitions are due to systems-level feedback. Nat. Cell Biol. 9, 724–728. 10.1038/ncb0707-724
57
ParsonsR. (1998). Phosphatases and tumorigenesis. Curr. Opin. Oncol. 10, 88–91.
58
PendergastJ. S.YeomM.ReyesB. A.OhmiyaY.YamazakiS. (2010). Disconnected circadian and cell cycles in a tumor-driven cell line. Commun. Integr. Biol. 3, 536–539. 10.4161/cib.3.6.12841
59
PfeutyB. (2012). Strategic cell-cycle regulatory features that provide mammalian cells with tunable G1 length and reversible G1 arrest. PLoS ONE7:e35291. 10.1371/journal.pone.0035291
60
PomereningJ. R.KimS. Y.FerrellJ. E.Jr. (2005). Systems-level dissection of the cell-cycle oscillator: bypassing positive feedback produces damped oscillations. Cell122, 565–578. 10.1016/j.cell.2005.06.016
61
PomereningJ. R.SontagE. D.FerrelJ. E.Jr. (2003). Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2. Nat. Cell Biol. 5, 346–351. 10.1038/ncb954
62
QuZ.WeissJ. N.MacLellanW. R. (2003). Regulation of the mammalian cell cycle: a model of the G1-to-S transition. Am. J. Physiol. Cell Physiol. 284, 349–364. 10.1152/ajpcell.00066.2002
63
QuaroniA.TianJ. Q.SethP.Ap RhysC. (2000). p27Kip1 is an inducer of intestinal epithelial cell differentiation. Am. J. Physiol. Cell Physiol. 279, C1045–C1057.
64
RayD.KiyokawaH. (2008). CDC25A phosphatase: a rate-limiting oncogene that determines genomic stability. Cancer Res. 68, 1251–1253. 10.1158/0008-5472.CAN-07-5983
65
SaharS.Sassone-CorsiP. (2009). Metabolism and cancer: the circadian clock connection. Nat. Rev. Cancer9, 886–896. 10.1038/nrc2747
66
SantamariaD.BarrièreC.CerqueiraA.HuntS.TardyC.NewtonK.et al. (2007). Cdk1 is sufficient to drive the mammalian cell cycle. Nature448, 811–815. 10.1038/nature06046
67
SegelL. A. (1988). On the validity of the steady state assumption of enzyme kinetics. Bull. Math. Biol. 50, 579–593.
68
ShaW.MooreJ.ChenK.LassaletaA. D.YiC.-S.TysonJ. J.et al. (2003). Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts. Proc. Natl. Acad. Sci. U.S.A. 100, 975–980. 10.1073/pnas.0235349100
69
SkotheimJ. M.Di TaliaS.SiggiaE. D.CrossF. R. (2008). Positive feedback of G1 cyclins ensures coherent cell cycle entry. Nature454, 291–296. 10.1038/nature07118
70
SmithL. M.WiseS. C.HendricksD. T.SabichiA. L.BosT.ReddyP.et al. (1999). cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene18, 6063–6070. 10.1038/sj.onc.1202989
71
SorensenC. S.LukasC.KramerE. R.PetersJ.-M.BartekJ.LukasJ. (2000). Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis. Mol. Cell. Biol. 20, 7613. 10.1128/MCB.20.20.7613-7623.2000
72
SwatM.KelA.HerzelH. (2004). Bifurcation analysis of the regulatory modules of the mammalian G1/S transition. Bioinformatics20, 1506–1511. 10.1093/bioinformatics/bth110
73
TrunnellN. B.PoonA. C.KimS. Y.FerrellJ. E.Jr. (2011). Ultrasensitivity in the regulation of Cdc25C by Cdk1. Mol. Cell41, 263–274. 10.1016/j.molcel.2011.01.012
74
TysonJ. J.BaumannW. T.ChenC.VerdugoA.TavassolyI.WangY.et al. (2011). Dynamic modeling of oestrogen signaling and cell fate in breast cancer cells. Nat. Rev. Cancer11, 523–532. 10.1038/nrc3081
75
YaoG.LeeT. J.MoriS.NevinsJ. R.YouL. (2008). A bistable Rb-E2F switch underlies the restriction point. Nat. Cell Biol. 10, 476–482. 10.1038/ncb1711
76
YokoiS.YasuiK.MoriM.lizasaT.FujisawaT.InazawaJ. (2004). Amplification and overexpression of Skp2 are associated with metastasis of non-small-cell lung cancers to lymph nodes. Am. J. Pathol. 165, 175–180. 10.1016/S0002-9440(10)63286-5
Summary
Keywords
cell cycle, computational model, Cdk oscillations, limit cycle, quiescence, proliferation, cellular rhythms
Citation
Gérard C and Goldbeter A (2012) From quiescence to proliferation: Cdk oscillations drive the mammalian cell cycle. Front. Physio. 3:413. doi: 10.3389/fphys.2012.00413
Received
03 August 2012
Accepted
04 October 2012
Published
02 November 2012
Volume
3 - 2012
Edited by
Matteo Barberis, Humboldt University Berlin, Germany; Max Planck Institute for Molecular Genetics, Berlin, Germany
Reviewed by
Pavel Kraikivski, Virginia Polytechnic Institute and State University, USA; Attila Csikasz-Nagy, The Microsoft Research - University of Trento COSBI, Italy
Copyright
© 2012 Gérard and Goldbeter.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
*Correspondence: Albert Goldbeter, Faculté des Sciences, Université Libre de Bruxelles (ULB), Campus Plaine, CP 231, B-1050 Brussels, Belgium. e-mail: agoldbet@ulb.ac.be
This article was submitted to Frontiers in Systems Biology, a specialty of Frontiers in Physiology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.